TARA EBITDA Growth
Protara Therapeutics Inc · EBITDA Growth
TARA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-37.92%period ending
TARA TTM EBITDA YoY % (-1073.22% → -37.92%)
Year-over-year change
High-resolution chart · PNG
TARA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -37.9234% | |
| -39.6047% | |
| -28.9468% | |
| -26.0464% | |
| -25.2324% | |
| -7.027% | |
| -10.4419% | |
| -4.5333% | |
| -7.6946% | |
| -22.5254% | |
| -12.2661% | |
| -17.1617% | |
| -3.2302% | |
| 14.8339% | |
| 17.4165% | |
| 22.3913% | |
| 14.2293% | |
| -8.1352% | |
| -26.0721% | |
| -92.1615% | |
| -186.005% | |
| -395.16% | |
| -1,433.6878% | |
| -336.6897% | |
| -52.2467% | |
| 48.2389% | |
| 112.4721% | |
| 74.9964% | |
| 66.1333% | |
| 50.471% | |
| 30.8626% | |
| 33.0483% | |
| -10.2163% | |
| -3.875% | |
| -3.9936% | |
| -11.6539% | |
| -0.2002% | |
| -22.5435% | |
| -37.1621% | |
| -276.3795% | |
| -1,073.2159% |